South Carolina has grown faster than its specialty care has — and GLP-1 telehealth is one of the most useful workarounds.
South Carolina is one of the fastest-growing states in the country, and its specialty care infrastructure has not kept pace with the population boom. Charleston, Greenville, Columbia, the Myrtle Beach corridor, Hilton Head, and Bluffton have all added tens of thousands of residents in the past decade without a proportional increase in endocrinology, bariatric medicine, or weight-loss-focused primary care. The result is a state where demand for GLP-1 medications is high and traditional access is constrained. Telehealth has become the most direct workaround.
South Carolina has elevated adult obesity rates and significant rates of type 2 diabetes, particularly in the Pee Dee and Lowcountry regions. The Lowcountry food culture — built around shrimp and grits, fried seafood, slow-cooked vegetables, and signature comfort foods — is one of the great regional cuisines, and it's also energy-dense in ways that make sustainable weight loss through diet alone genuinely hard. GLP-1 receptor agonists work on the appetite-regulation circuitry directly, which means they help patients moderate intake without forcing them to abandon the food culture they live in.
The patient books a consult, completes a medical history, and meets with a South Carolina-licensed provider on video. The provider screens for contraindications, reviews medications, and orders baseline labs (A1c, comprehensive metabolic panel, lipid panel) to a Quest or LabCorp draw site. Quest and LabCorp have locations in Charleston, Mount Pleasant, North Charleston, Summerville, Columbia, Lexington, Greenville, Spartanburg, Anderson, Rock Hill, Florence, Myrtle Beach, Hilton Head, Bluffton, and more. After labs come back, the prescription is sent to the patient's preferred pharmacy or ships from a partner compounding pharmacy.
BlueCross BlueShield of South Carolina, Healthy Connections Medicaid, Absolute Total Care, and Select Health of South Carolina all cover GLP-1 medications under varying conditions. BCBSSC commercial plans frequently cover Wegovy and Zepbound with prior authorization (typical thresholds: BMI 30+ with comorbidity, BMI 35+ without, documented prior weight loss attempts). Healthy Connections Medicaid covers GLP-1s for type 2 diabetes; weight-loss-only coverage is more limited. Many cash-pay patients land with us because the predictable monthly fee for a compounded GLP-1 program is competitive with insurance copays plus required clinic visits.
Most South Carolina adults with a BMI of 30+ (or 27+ with a weight-related comorbidity such as hypertension, prediabetes, dyslipidemia, sleep apnea, or PCOS) are eligible. Contraindications include personal or family history of medullary thyroid carcinoma, MEN-2 syndrome, severe gastroparesis, active pancreatitis, and pregnancy or active attempts to conceive. Patients with active eating disorders or significant gallbladder disease may need a modified protocol.
Standard semaglutide titration: 0.25 mg weekly for the first month, increasing every four weeks based on response and tolerance. Tirzepatide follows a similar weekly titration. Most patients notice meaningful appetite suppression within the first two weeks. Body weight reductions of 5–7% by month three and 10–15% by month six are typical at maintenance dosing. Side effects (nausea, constipation, occasional reflux) cluster around dose increases and resolve within several days. Hydration matters more during titration than most patients expect — particularly relevant in South Carolina's summer heat and humidity.
Worth noting because it comes up: GLP-1 medications can slightly suppress thirst signaling, and the side-effect profile (nausea, occasional vomiting during titration) increases hydration risk. South Carolina summers — particularly in Charleston, the Lowcountry, and the coast — push heat index well into dangerous territory. Patients on GLP-1 therapy should be deliberate about water intake during the warmer months, particularly if they're working outdoors or training in the heat. Most providers recommend tracking fluid intake during titration phases that fall in summer.
Charleston has MUSC and the broader Trident health system, but appointment lead times for weight-loss-focused providers run weeks to months. Columbia and the Midlands have similar dynamics. Greenville and the Upstate have grown rapidly and specialty access has not kept pace. Myrtle Beach and the Grand Strand have always been thin on dedicated weight-loss specialty capacity, and telehealth provides a practical alternative for the area's growing year-round population. Hilton Head, Bluffton, and Beaufort are similarly served well by telehealth.